Gabbi logo

Gabbi

Making late stage Breast Cancer obsolete

23 employees · est. 2020 · Portland, United States

VS
Niramai Health Analytix logo

Niramai Health Analytix

A non-contact privacy-aware breast cancer screening solution that detects early stage breast abnormalities.

74 employees · est. 2016 · Bengaluru, India

Niramai Health Analytix is the older company (2020 vs 2016); Niramai Health Analytix is the larger of the two.

Side-by-Side Comparison

Gabbi Niramai Health Analytix
Founded
2020 2016 older
Headquarters
Portland, United States Bengaluru, India
Employees
23 74 larger
Industry
Health Care, Health and Wellness, Women's Health Health Care
Funding Stage
Seed Unknown
Total Funding
$6.22M $7.18M
Funding Rounds
6 9
Services
breast cancer risk assessment, personalized care planning, virtual consultations with specialists, ordering and scheduling diagnostic tests, follow-up care management Not tracked yet
Target Customers
women at risk of breast cancer, employers offering healthcare benefits, health systems seeking integration solutions, healthcare providers, women seeking personalized preventive care Not tracked yet
Taxonomy
Breast Cancer, Risk Assessment, Early Detection, Medical Innovation, Women's Health, Cancer Screening, Medical Diagnostics, Precision Medicine Health Tech, AI-based Healthcare, Breast Cancer Screening, Deep Learning Algorithms, Thermography, Medical Imaging, Non-invasive Screening, Women's Health, Early Cancer Detection, Medical Technology, Privacy-aware Solutions
Website
gabbi.com niramai.com
Gabbi logo

About Gabbi

Gabbi is positioning itself as a pioneer in women's health by focusing on early detection of breast cancer to render late-stage diagnoses obsolete. Founded in 2020, the company offers a groundbreaking breast cancer risk assessment and detection solution that claims to deliver immediate and accurate...

Niramai Health Analytix logo

About Niramai Health Analytix

Niramai Health Analytix is a pioneering health tech startup founded in 2016 and headquartered in India, specializing in the early detection of breast cancer through its innovative Thermalytix® technology. Their solution provides a non-contact privacy-aware breast cancer screening offering, which is...

We will tell you when either one moves

BounceWatch watches Gabbi and Niramai Health Analytix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Gabbi and Niramai Health Analyti... — by email.

Frequently Asked Questions

Gabbi — Making late stage Breast Cancer obsolete . Niramai Health Analytix — A non-contact privacy-aware breast cancer screening solution that detects early stage breast abnormalities.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Gabbi has raised $6.22M while Niramai Health Analytix has raised $7.18M.
Gabbi and Niramai Health Analytix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Gabbi with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Gabbi on 11 Sep 2024, and Niramai Health Analytix on 29 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes